Good MorningThe selloff in equities resumed on Thursday as traders brace for what could be an historic PCE price index. Although the index is expected to decelerate on a YOY basis it is expected to remain high and at a level that confirms the latest twist in the FOMC outlook. The twist is that the FOMC slowed the rate hike pace but upped its expectations for both inflation and peak interest rates.
Thursday’s candle is a warning to the market. Investors hoping for a Santa Claus Rally should be cautious. The market may rise next week simply because of a lack of volume and the "underlying bid". In this scenario, any upswing in prices will likely be met by selling that drives the index down to a new low Featured: The 7 Best Stocks to Own in Summer 2025 (Ad) 
|
Stocks | | |
As temperatures drop throughout the U.S., sunshine and warmth may seem like distant dreams. But for shareholders of top-performing solar-energy stocks such as Enphase Energy Inc. (NASDAQ: ENPH), SolarEdge Technologies Inc. (NASDAQ: SEDG), and First Solar Inc. (NASDAQ: FSLR), those brighter days ma... Read the Full Story |
|
From Our Partners | | Cold War Discovery Could Unlock $100 Trillion in Wealth
Jeff recently traveled to an American ghost town to investigate this crazy Cold War story…
Because it could hold the key to the entire $100 trillion AI boom.
It involves an American ghost town with just 30 people…
And a new twist to the AI boom that could make a lot of people rich. | | Click here to see the details on what could be the biggest tech story of this decade. |
|
Stocks | | | Stocks closed modestly higher on Wall Street, while bond markets around the world felt pain after a surprise move from Japan’s central bank cranked the pressure even higher on the already slowing global economy Read the Full Story |
|
Markets | | | Shares declined in Asia on Friday after a retreat on Wall Street driven by fears that strong economic data will lead the Federal Reserve to double down on its interest rate hikes to tame inflation.
Shanghai was flat while other major indexes declined. U.S. futures edged higher and oil... Read the Full Story |
|
From Our Partners | | CPA and CFA says you have WAY too many stocks - just buy these 3
After years working at the biggest accounting firms like Deloitte and KPMG, Joel Litman (who’s also a member of the Global CFA Institute) figured out a unique, less-risky way to grow rich in the stock market. Litman says you don’t need dozens of investments, overpriced advisers, or hedge funds. You just need these 3 stocks, which have helped Litman’s own mom earn 3,400%. | | Click here to view… |
|
Markets | | |
Well, it was fun while it lasted. Traders had some holiday fun with Palantir Technologies Inc. (NYSE: PLTR) stock a few days before the Christmas holiday. On December 21, PLTR shares went up 5% on the news that Palantir was awarded a multi-million deal with the United Kingdom's Ministry of De... Read the Full Story |
|
Stocks | | |
You may think of equipment makers Caterpillar Inc. (NYSE: CAT) and Deere & Company (NYSE: DE) as literally moving slowly, but these heavy equipment stocks outran the S&P 500 throughout 2022 and pulled into a sprint to end the year.
Despite its name, Caterpillar hasn’t exactly been c... Read the Full Story |
|
From Our Partners | Most traders guess. This system doesn’t.
Using his Momentum Indicator, one trader turned $15K into $150K in six months — stacking 20–30% daily gains. Now he’s sharing 3 stocks flashing BUY right now, plus a free report showing how to trade them. | | Claim your 3 stock picks + free momentum trading report |
|
Markets | | |
On a day when the broader market soared over 500 points, Lucid Group, Inc. (NASDAQ: LCID) was a notable laggard. Shares of LCID stock fell by less than one percent. But it continues the downward trend for the stock, down 30% in the last month and over 80% in 2022.
One sore spot for investor... Read the Full Story |
|
Markets | | | Shares rose in Europe on Friday after a retreat in Asia ahead of updates on U.S. consumer spending and durable goods orders.
Benchmarks climbed in London and Paris but fell in Hong Kong, Tokyo and Seoul. Oil prices surged more than $1 a barrel.
Japan reported its core... Read the Full Story |
|
Markets | | | World shares are mixed after a rally on Wall Street as investors welcomed a report showing U.S. consumer confidence is holding up despite the Federal Reserve's campaign to fight inflation by raising interest rates Read the Full Story |
|
Stocks | | | Shares were mixed in Asia on Wednesday after a modestly higher close on Wall Street as concerns over pressures on global growth tempered gains in the absence of major data releases.
Tokyo’s benchmark Nikkei 225 index slipped 0.2%, to 26,387.72, a day after the Bank of Japan gave in t... Read the Full Story |
|
Markets | | |
Mullen Automotive, Inc. (NASDAQ: MULN) stock is up nearly 4% (3.95%) in midday trading on news that the company's first I-GO™ vehicles have arrived in Europe. The I-GO™ is an urban commercial delivery vehicle purposefully designed to meet the space constraints in dense cities thro... Read the Full Story |
|
Friday's Early Bird Stock Of The Day Iovance Biotherapeutics, Inc., a commercial-stage biotechnology company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States. The company offers Amtagvi, a tumor-derived autologous T cell immunotherapy used to treat adult patients with unresectable or metastatic melanoma; and Proleukin, an interleukin-2 product for the treatment of patients with metastatic renal cell carcinoma. It also develops lifileucel in combination with pembrolizumab to treat frontline advanced melanoma patients; LN-145 for the treatment of non-small cell lung cancer (NSCLC) and solid tumor cancers; IOV-4001, which is in Phase 1/2 IOV-GM1-201 clinical trial, for the treatment of NSCLC; and lifileucel for gynecological cancers. The company has collaborations and licensing agreements with WuXi Advanced Therapies, Inc.; National Institutes of Health; the National Cancer Institute; H. Lee Moffitt Cancer Center; The University of Texas M.D. Anderson Cancer Center; Cellectis S.A.; Novartis Pharma AG; and Boehringer Ingelheim Biopharmaceuticals GmbH. The company was formerly known as Lion Biotechnologies, Inc. and changed its name to Iovance Biotherapeutics, Inc. in June 2017. Iovance Biotherapeutics, Inc. was incorporated in 2007 and is headquartered in San Carlos, California. | | View Today's Stock Pick |
|
